acecainide has been researched along with Bright Disease in 1 studies
Acecainide: A major metabolite of PROCAINAMIDE. Its anti-arrhythmic action may cause cardiac toxicity in kidney failure.
N-acetylprocainamide : A benzamide obtained via formal condensation of 4-acetamidobenzoic acid and 2-(diethylamino)ethylamine.
Bright Disease: A historical classification which is no longer used. It described acute glomerulonephritis, acute nephritic syndrome, or acute nephritis. Named for Richard Bright.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nguyen, KP | 1 |
| Thomsen, G | 1 |
| Liem, B | 1 |
| Swerdlow, CD | 1 |
| Franz, MR | 1 |
1 other study available for acecainide and Bright Disease
| Article | Year |
|---|---|
N-acetylprocainamide, torsades de pointes, and hemodialysis.
Topics: Acecainide; Adult; Female; Glomerulonephritis; Humans; Procainamide; Renal Dialysis; Tachycardia | 1986 |